Sareum (SAR) AGM 2024 summary

Opening remarks and agenda

• Meeting opened with thanks to Canaccord Genuity for hosting and acknowledgment of hybrid in-person and online attendance.

• Formal business addressed first, followed by a Q&A session for both in-person and online questions.

• Board members introduced, and confirmation of proper notice for the meeting was given.

Overview of voting outcomes

• All nine resolutions, including adoption of financial statements, remuneration report, director re-elections, auditor reappointment, and share allotment authorities, were passed by the necessary majorities.

• Proxy votes represented 9.4% of total shares outstanding.

Board and executive committee updates

• Appointment of Cavendish as a joint broker alongside Hybridan to enhance market visibility and access.

• Board reaffirmed the strategy to partner discoveries at late preclinical or early clinical stages, with flexibility to advance assets independently if needed.